Free Trial

SunOpta (NASDAQ:STKL) Upgraded to "Hold" at StockNews.com

SunOpta logo with Consumer Staples background

StockNews.com upgraded shares of SunOpta (NASDAQ:STKL - Free Report) TSE: SOY from a sell rating to a hold rating in a research report report published on Saturday morning.

Other analysts have also issued reports about the stock. Stephens lifted their price target on shares of SunOpta from $9.00 to $10.00 and gave the stock an "overweight" rating in a research note on Wednesday. DA Davidson reaffirmed a "buy" rating and issued a $9.00 target price on shares of SunOpta in a research report on Thursday, October 10th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, SunOpta presently has an average rating of "Moderate Buy" and a consensus price target of $9.50.

View Our Latest Research Report on STKL

SunOpta Stock Down 2.1 %

NASDAQ STKL traded down $0.16 during mid-day trading on Friday, reaching $7.29. The stock had a trading volume of 674,472 shares, compared to its average volume of 811,304. The stock has a market cap of $870.78 million, a PE ratio of -40.50 and a beta of 1.83. SunOpta has a 1 year low of $3.85 and a 1 year high of $7.59. The company has a debt-to-equity ratio of 1.61, a current ratio of 1.20 and a quick ratio of 0.61. The company has a fifty day moving average price of $6.33 and a 200 day moving average price of $5.89.

SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last posted its earnings results on Tuesday, November 5th. The company reported $0.02 EPS for the quarter, hitting analysts' consensus estimates of $0.02. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%. The business had revenue of $176.22 million during the quarter, compared to analyst estimates of $172.30 million. On average, research analysts expect that SunOpta will post 0.14 earnings per share for the current year.

Insider Transactions at SunOpta

In other news, insider Robert Duchscher sold 50,000 shares of SunOpta stock in a transaction on Friday, November 8th. The shares were sold at an average price of $7.33, for a total transaction of $366,500.00. Following the transaction, the insider now owns 42,971 shares in the company, valued at $314,977.43. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 6.48% of the company's stock.

Institutional Trading of SunOpta

Hedge funds and other institutional investors have recently bought and sold shares of the stock. First Bank & Trust grew its stake in shares of SunOpta by 7.9% during the 3rd quarter. First Bank & Trust now owns 25,409 shares of the company's stock valued at $162,000 after acquiring an additional 1,856 shares during the period. Mackenzie Financial Corp lifted its holdings in SunOpta by 0.9% during the second quarter. Mackenzie Financial Corp now owns 254,678 shares of the company's stock valued at $1,370,000 after purchasing an additional 2,155 shares in the last quarter. Creative Planning boosted its position in shares of SunOpta by 9.3% in the third quarter. Creative Planning now owns 30,716 shares of the company's stock worth $196,000 after purchasing an additional 2,617 shares during the period. Price T Rowe Associates Inc. MD increased its stake in shares of SunOpta by 13.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,913 shares of the company's stock worth $185,000 after purchasing an additional 3,171 shares in the last quarter. Finally, The Manufacturers Life Insurance Company raised its position in shares of SunOpta by 10.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 36,958 shares of the company's stock valued at $200,000 after purchasing an additional 3,521 shares during the period. Hedge funds and other institutional investors own 85.39% of the company's stock.

About SunOpta

(Get Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

Read More

Should you invest $1,000 in SunOpta right now?

Before you consider SunOpta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.

While SunOpta currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines